Bal Pharma (BALPHARMA) Shareholding Pattern

NSE: BALPHARMA • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 50.86%
FII Holding 0.22%
DII Holding 0.00%
Public Holding 32.97%
Total Shareholders 15,774
As of Sept 2025
View the latest shareholding pattern of Bal Pharma (BALPHARMA) including promoter, FII, DII, and public holdings. Track BALPHARMA ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See BALPHARMA quarterly performance)

Bal Pharma (BALPHARMA) Shareholding Summary

  • Promoter holding remains unchanged at 50.86% in Sept 2025
  • FII/FPI have increased holdings from 0.15% to 0.22% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Institutional investors have increased holdings from 0.15% to 0.22% in Sept 2025
  • Public holding has increased from 32.41% to 32.97% in Sept 2025
  • Number of shareholders decreased from 15,826 to 15,774 in Sept 2025

BALPHARMA Quarterly Ownership Changes

Quarter-over-quarter changes for Bal Pharma from Jun 2025 to Sept 2025.

Promoter Holding Change
Jun 2025 to Sept 2025
No Change
FII Holding Change
Jun 2025 to Sept 2025
+0.07%
DII Holding Change
Jun 2025 to Sept 2025
No Change
Public Holding Change
Jun 2025 to Sept 2025
+0.56%

Bal Pharma (BALPHARMA) Quarterly Shareholding Trends

Visual breakdown of BALPHARMA ownership distribution over time. Learn more about BALPHARMA complete financial.

Promoter
FII
DII
Public
Government

Rising institutional holdings in BALPHARMA often correlate with improved fundamentals. Check out BALPHARMA dividend payout details.

Bal Pharma (BALPHARMA) Shareholding Data

Download complete BALPHARMA ownership data for offline analysis. Discover BALPHARMA intrinsic value calculation.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 50.86% 0.22% 0.00% 0.00% 32.97% 15.94% 99.99% 15,774
Jun 2025 50.86% 0.15% 0.00% 0.00% 32.41% 16.58% 100.00% 15,826
Mar 2025 50.86% 0.14% 0.00% 0.00% 32.49% 16.51% 100.00% 15,723
Dec 2024 50.86% 0.14% 0.00% 0.00% 32.57% 16.43% 100.00% 15,667
Sept 2024 50.86% 0.13% 0.00% 0.00% 33.15% 15.86% 100.00% 16,007
Jun 2024 51.23% 0.13% 0.00% 0.00% 32.36% 16.28% 100.00% 15,014
Mar 2024 51.23% 0.13% 0.00% 0.00% 32.15% 16.49% 100.00% 14,772
Dec 2023 51.23% 0.00% 0.00% 0.00% 32.63% 16.13% 99.99% 15,060
Sept 2023 51.61% 0.00% 0.00% 0.00% 32.19% 16.20% 100.00% 15,529
Jun 2023 51.61% 0.00% 0.00% 0.00% 32.00% 16.40% 100.01% 15,869
Mar 2023 51.61% 0.00% 0.00% 0.00% 32.07% 16.32% 100.00% 16,029
Dec 2022 51.61% 0.00% 0.00% 0.00% 32.13% 16.26% 100.00% 16,466
Sept 2022 52.00% 0.00% 0.00% 0.00% 31.49% 16.52% 100.01% 16,170
Jun 2022 52.00% 0.00% 0.00% 0.00% 31.45% 16.55% 100.00% 16,317
Apr 2022 52.00% 0.00% 0.00% 0.00% 31.30% 16.70% 100.00% 16,223
Mar 2022 49.57% 0.00% 0.00% 0.00% 32.88% 17.55% 100.00% 16,223
Dec 2021 49.57% 0.00% 0.00% 0.00% 32.97% 17.46% 100.00% 16,049
Sept 2021 46.87% 0.00% 0.00% 0.00% 35.73% 17.40% 100.00% 16,319
Jun 2021 44.84% 0.00% 0.00% 0.00% 38.37% 16.79% 100.00% 16,531
Mar 2021 44.98% 0.00% 0.00% 0.00% 37.31% 17.72% 100.01% 12,648

BALPHARMA promoter holding above 50% indicates strong insider confidence. Explore the BALPHARMA P/B ratio history for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 50.86% 0.22% 0.00% 0.00% 32.97% 15.94% 99.99% 15,774
Jun 2025 50.86% 0.15% 0.00% 0.00% 32.41% 16.58% 100.00% 15,826
Mar 2025 50.86% 0.14% 0.00% 0.00% 32.49% 16.51% 100.00% 15,723
Dec 2024 50.86% 0.14% 0.00% 0.00% 32.57% 16.43% 100.00% 15,667
Sept 2024 50.86% 0.13% 0.00% 0.00% 33.15% 15.86% 100.00% 16,007
Jun 2024 51.23% 0.13% 0.00% 0.00% 32.36% 16.28% 100.00% 15,014
Mar 2024 51.23% 0.13% 0.00% 0.00% 32.15% 16.49% 100.00% 14,772
Dec 2023 51.23% 0.00% 0.00% 0.00% 32.63% 16.13% 99.99% 15,060
Sept 2023 51.61% 0.00% 0.00% 0.00% 32.19% 16.20% 100.00% 15,529
Jun 2023 51.61% 0.00% 0.00% 0.00% 32.00% 16.40% 100.01% 15,869
Mar 2023 51.61% 0.00% 0.00% 0.00% 32.07% 16.32% 100.00% 16,029
Dec 2022 51.61% 0.00% 0.00% 0.00% 32.13% 16.26% 100.00% 16,466

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 50.86% 0.14% 0.00% 0.00% 32.49% 16.51% 100.00% 15,723
Dec 2024 50.86% 0.14% 0.00% 0.00% 32.57% 16.43% 100.00% 15,667
Dec 2023 51.23% 0.00% 0.00% 0.00% 32.63% 16.13% 99.99% 15,060
Dec 2022 51.61% 0.00% 0.00% 0.00% 32.13% 16.26% 100.00% 16,466
Dec 2021 49.57% 0.00% 0.00% 0.00% 32.97% 17.46% 100.00% 16,049

Year-over-year trends reveal long-term ownership shifts.

Understanding Bal Pharma (BALPHARMA) Shareholding Pattern

Bal Pharma shareholding pattern reveals who owns BALPHARMA stock and how ownership changes over time. High promoter stakes in BALPHARMA often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your BALPHARMA trades. Bal Pharma yearly highs lows

Combine BALPHARMA ownership analysis with price movements and financial performance for a complete investment picture. (See BALPHARMA investment value)